Albireo Energy, a leading independent building controls and energy services provider, and Huron Capital portfolio company, ...
According to GlobalData’s company profile on Albireo Pharma, was a key innovation area identified from patents. Albireo Pharma's grant share as of February 2024 was 57%. Grant share is based on the ...
The Albireo Pharma stock forecast for tomorrow is $ 44.15, which would represent a 0.00% gain compared to the current price. In the next week, the price of ALBO is expected to increase by 0.00% and ...
USA-based rare seizure specialist Marinus Pharmaceuticals saw its shares crash, falling nearly 83% to $1.36, after it revealed that a trial failed to meet early stopping criteria. The US Centers for ...